Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0370
+0.0010 (2.78%)
At close: Feb 19, 2026
Entropy Neurodynamics Revenue
In the fiscal year ending June 30, 2025, Entropy Neurodynamics had annual revenue of 1.58M AUD with 19.17% growth. Entropy Neurodynamics had revenue of 790.84K in the quarter ending June 30, 2025.
Revenue
1.58M
Revenue Growth
+19.17%
P/S Ratio
37.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
59.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.58M | 254.43K | 19.17% |
| Jun 30, 2024 | 1.33M | - | - |
| Aug 31, 2023 | - | - | - |
| Aug 31, 2022 | - | - | - |
| Aug 31, 2021 | - | - | - |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EZZ Life Science Holdings | 66.87M |
| Radiopharm Theranostics | 12.51M |
| Alterity Therapeutics | 5.44M |
| Amplia Therapeutics | 5.01M |
| Imugene | 4.40M |
| Prescient Therapeutics | 4.36M |
| Proteomics International Laboratories | 3.31M |
| Cynata Therapeutics | 1.89M |